share_log

Navigating 14 Analyst Ratings For Amgen

Navigating 14 Analyst Ratings For Amgen

瀏覽安進的14個分析師評級
Benzinga ·  10/22 15:01  · 評級/大行評級
Analysts' ratings for Amgen (NASDAQ:AMGN) over the last quarter vary from bullish to bearish, as provided by 14 analysts.
上個季度安進(納斯達克股票代碼:AMGN)的分析師評級從看好到看淡不一,共有14位分析師提供。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照,展示了情緒在過去30天中的演變情況,並將其與之前的月份進行比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $349.36, a high estimate of $405.00, and a low estimate of $215.00. This upward trend is apparent, with the current average reflecting a 4.55% increase from the previous average price target of $334.17.
分析師通過對12個月價格目標的評估提供更深入的見解,顯示出平均目標爲349.36美元,高估爲405.00美元,低估爲215.00美元。這種上升趨勢是明顯的,當前平均值反映比之前的平均價格目標334.17美元增長了4.55%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級:全面解析
A comprehensive examination of how...
最近的分析...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論